Entheogens in the study of religious experiences: Current status

Journal of Religion and Health

Volumn 44, Issue 4, 2005, Pages 377-389

  Richards, William A ^a  

^a Council on Spritual Practices ^*

Author keywords

Archetypal experiences; Consciousness; Entheogens; Mystical experiences

Indexed keywords

EID: 28144441884     PISSN: 00224197     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10943-005-7177-8     Document Type: Article

References (40)

1. Brecht, B. (1955 [1939]). Leben des Galilei, Berlin: Suhrkamp.
2. Cohen, S. (1960). Lysergic acid diethylamide:Side effects and complications. Journal of Nervous and Mental Disease, 130, 30-40.
3. D'Aquili, E. and Newberg, A.B. (1999). The Mystical Mind: Probing the Biology of Religious Experience. Minneapolis: Fortress Press.
4. Eck, D.L. (1993). Encountering God. Boston: Beacon Press.
5. Gable, R.S. (1993). Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically. American Journal of Drug and Alcohol Abuse, 19, 263-281.
6. Grof, S. (1975). Realms of the Human Unconscious: Observations from LSD Research. NY: Viking Press.
7. Hart, M. (1968). The Oneness in God, The Vision of Christ, The Crucifixion. In R. Metzner (ed.). The Ecstatic Adventure (pp. 80-81). NY: Macmillan, Reprinted by permission of Ralph Metzner.
8. Huxley, A. (1963). The Doors of Perception and Heaven and Hell. NY: Harper & Row.
9. Jaspers, K. (1954). Way to Wisdom. R. Manheim, trans. New Haven : Yale University Press.
10. Jesse, R. (2001). On Nomenclature. In T.B. Roberts (ed.). Psychoactive Sacramentals: Essays on Entheogens and Religion (pp. 225-231). San Francisco: Council on Spiritual Practices.
11. Jung, C.G., (1959). Collected Works, trans. R.F.C. Hull, Vol. 9. (pp. 4-5). NY: Pantheon.
12. Kurland, A.A., Savage, C., Pahnke, W.N., Grof, S., and Olsson, J. (1971). LSD in the treatment of alcoholics. Pharmakopsychiatrie and Neuro-Psychopharmakologie, 4, 83-94.
13. LeBarre, W. (1938). The Peyote Cult. New Haven: Yale University Press.
14. Maslow, A. (1964). Religions, Values and Peak Experiences. Columbus: Ohio State University Press.
15. Maslow, A. (1966). The Psychology of Science: A Reconnaissance. NY: Harper and Row.
16. Narby, J. (1998). The Cosmic Serpent: DNA and the Origins of Knowledge. NY: Tarcher.
17. Newberg, A, and D'Aquili, E. (2001). Why God Won't Go Away: Brain Science & The Biology of Belief. NY: Ballantine Books.
18. Pahnke, W.N. and Richards, W.A. (1966). Implications of LSD and experimental mysticism, Journal of Religion and Health, 5, 175-208.
19. Rhead, J.C., Soskin, R.A., Turek, I., Richards, W.A, Yensen, R., Kurland, A. A., and Ota, K.Y. (1977). Psychedelic drug (DPT)-assisted psychotherapy with alcoholics: A controlled study. Journal of Psychedelic Drugs, 9, 287-300.
20. Richards, W.A. (2002). Entheogens in the study of mystical and archetypal experiences. Research in the Social Scientific Study of Religion, 13, 143-155.
21. Richards, W.A. (1978). Mystical and archetypal experiences of terminal patients in DPT-assisted psychotherapy. Journal of Religion and Health, 17, 117-126.
22. Richards, W.A. (1980). Psychedelic drug-assisted psychotherapy with persons suffering from terminal cancer. Journal of Altered States of Consciousness, 5, 309-319.
23. Richards, W.A., Grof, S., Goodman, L.E., and Kurland, A.A. (1972). LSD-assisted psychotherapy and the human encounter with death. Journal of Transpersonal Psychology, 3, 121-150.
24. Richards, W.A., Rhead, J.C., DiLeo, F.B., Yensen, R., and Kurland, A.A. (1977). The peak experience variable in DPT-assisted psychotherapy with cancer patients. Journal of Psychedelic Drugs, 9, 1-10.
25. Savage, C. and McCabe, O.L. (1973). Residential psychedelic (LSD) therapy for the narcotic addict: a controlled study. Archives of General Psychiatry, 28, 808-814.
26. Shulgin, A. and Shulgin, A (1991). PIHKAL:A Chemical Love Story. Berkeley: Transform Press.
27. Shulgin, A. and Shulgin, A. (1997). TIHKAL: The Continuation. Berkeley: Transform Press.
28. Smith, H. (2000). Cleansing the Doors of Perception: The Religious Significance of Entheogenic Plants and Chemicals. NY: Tarcher/Putnam.
29. Smith, H. and Snake, R. (1996). One Nation Under God: The Triumph of the Native American Church. Santa Fe: Clear Light Publishers.
30. Steindl-Rast, D. (2001). Foreward. In T,B. Roberts (ed.). Psychoactive Sacramentals: Essays on Entheogens and Religion. San Francisco: Council on Spiritual Practices.
31. Strassman, R.J. (1984). Adverse reactions to psychedelic drugs: A review of the literature. Journal of Nervous and Mental Disease, 172, 577-595.
32. Strassman, R, (2001). DMT: The Spirit Molecule, Rochester VT: Park Street Press.
33. Teasdale, W. (1999). The Mystic Heart: Discovering a Universal Spirituality in the World's Religions. Novato CA: New World Library.
34. Tillich, P. (1966). The Future of Religions. NY: Harper and Row.
35. Watts, A. (1966). The Book: On the Taboo Against Knowing Who You Are. NY: Pantheon.
36. Watts, A. (1962). The Joyous Cosmology: Adventures in the Chemistry of Consciousness. NY: Pantheon.
37. Yensen, R., DiLeo, F.B., Rhead, J.C., Richards, W.A., Soskin, R.A., Turek, B., and Kurland, A.A. (1976). MDA-assisted psychotherapy with neurotic outpatients: A pilot study. Journal of Nervous and Mental Disease, 163, 233-245.
38. Yensen, R. and Dryer, D. (1995). Thirty Years of Psychedelic Research: The Spring Grove Experiment and Its Sequels, Yearbook of the European College for the Study of Consciousness (ECBS) 1993-1994, (pp. 73-101). Berlin: Verlag für Wissenschaft und Bildung.
39. Zaehner, R.C. (1961). Mysticism, Sacred and Profane. NY: Galaxy Books 212-226.
40. Zaehner, R.C. (1954). The Menace of Mescalin. Blackfriars, 35, 412-413, p. 310.